nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—TOP1—colon cancer	0.251	0.894	CbGaD
Irinotecan—breast cancer—colon cancer	0.129	0.302	CtDrD
Irinotecan—stomach cancer—colon cancer	0.111	0.26	CtDrD
Irinotecan—pancreatic cancer—colon cancer	0.104	0.243	CtDrD
Irinotecan—lung cancer—colon cancer	0.0839	0.196	CtDrD
Irinotecan—CES1—Capecitabine—colon cancer	0.0673	0.327	CbGbCtD
Irinotecan—ABCB1—colon cancer	0.03	0.106	CbGaD
Irinotecan—SLC22A3—Vincristine—colon cancer	0.0227	0.11	CbGbCtD
Irinotecan—ABCC1—Vincristine—colon cancer	0.0148	0.0721	CbGbCtD
Irinotecan—ABCC2—Vincristine—colon cancer	0.011	0.0534	CbGbCtD
Irinotecan—ABCG2—Fluorouracil—colon cancer	0.0109	0.053	CbGbCtD
Irinotecan—ABCG2—Vincristine—colon cancer	0.00992	0.0483	CbGbCtD
Irinotecan—ABCC1—Methotrexate—colon cancer	0.00898	0.0437	CbGbCtD
Irinotecan—SLCO1B1—Methotrexate—colon cancer	0.00756	0.0368	CbGbCtD
Irinotecan—ALB—Fluorouracil—colon cancer	0.00751	0.0365	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.00733	0.0356	CbGbCtD
Irinotecan—CYP3A7—Vincristine—colon cancer	0.00733	0.0356	CbGbCtD
Irinotecan—ABCC2—Methotrexate—colon cancer	0.00664	0.0323	CbGbCtD
Irinotecan—ABCG2—Methotrexate—colon cancer	0.00601	0.0292	CbGbCtD
Irinotecan—CYP3A5—Vincristine—colon cancer	0.0055	0.0267	CbGbCtD
Irinotecan—ALB—Methotrexate—colon cancer	0.00414	0.0201	CbGbCtD
Irinotecan—ABCB1—Vincristine—colon cancer	0.00358	0.0174	CbGbCtD
Irinotecan—Topotecan—TOP1—colon cancer	0.0028	0.893	CrCbGaD
Irinotecan—ABCB1—Methotrexate—colon cancer	0.00217	0.0105	CbGbCtD
Irinotecan—CYP3A4—Vincristine—colon cancer	0.00214	0.0104	CbGbCtD
Irinotecan—ABCC2—bile—colon cancer	0.00172	0.0935	CbGeAlD
Irinotecan—CES1—gall bladder—colon cancer	0.000734	0.0398	CbGeAlD
Irinotecan—TOP1MT—liver—colon cancer	0.000546	0.0296	CbGeAlD
Irinotecan—UGT1A9—renal system—colon cancer	0.000531	0.0288	CbGeAlD
Irinotecan—ALB—gall bladder—colon cancer	0.00051	0.0277	CbGeAlD
Irinotecan—TOP1—smooth muscle tissue—colon cancer	0.00049	0.0266	CbGeAlD
Irinotecan—CES2—smooth muscle tissue—colon cancer	0.000444	0.0241	CbGeAlD
Irinotecan—UGT1A9—digestive system—colon cancer	0.000435	0.0236	CbGeAlD
Irinotecan—CES2—renal system—colon cancer	0.000428	0.0232	CbGeAlD
Irinotecan—TOP1MT—lymph node—colon cancer	0.000419	0.0227	CbGeAlD
Irinotecan—UGT1A1—renal system—colon cancer	0.000364	0.0197	CbGeAlD
Irinotecan—TOP1—bone marrow—colon cancer	0.000357	0.0193	CbGeAlD
Irinotecan—CES2—digestive system—colon cancer	0.000351	0.019	CbGeAlD
Irinotecan—TOP1—vagina—colon cancer	0.000342	0.0185	CbGeAlD
Irinotecan—Topotecan—ABCB1—colon cancer	0.000333	0.106	CrCbGaD
Irinotecan—UGT1A9—liver—colon cancer	0.000324	0.0176	CbGeAlD
Irinotecan—CES2—bone marrow—colon cancer	0.000323	0.0175	CbGeAlD
Irinotecan—SLC22A3—embryo—colon cancer	0.000323	0.0175	CbGeAlD
Irinotecan—CES2—vagina—colon cancer	0.00031	0.0168	CbGeAlD
Irinotecan—SLCO1B1—renal system—colon cancer	0.000303	0.0164	CbGeAlD
Irinotecan—UGT1A1—digestive system—colon cancer	0.000298	0.0162	CbGeAlD
Irinotecan—CES1—lymphoid tissue—colon cancer	0.000292	0.0159	CbGeAlD
Irinotecan—CES1—digestive system—colon cancer	0.000289	0.0157	CbGeAlD
Irinotecan—TOP1—liver—colon cancer	0.000288	0.0156	CbGeAlD
Irinotecan—CYP3A7—liver—colon cancer	0.00027	0.0146	CbGeAlD
Irinotecan—CES2—liver—colon cancer	0.000261	0.0142	CbGeAlD
Irinotecan—SLC22A3—smooth muscle tissue—colon cancer	0.000254	0.0138	CbGeAlD
Irinotecan—SLCO1B1—digestive system—colon cancer	0.000248	0.0135	CbGeAlD
Irinotecan—SLC22A3—renal system—colon cancer	0.000244	0.0133	CbGeAlD
Irinotecan—ABCC2—renal system—colon cancer	0.000229	0.0124	CbGeAlD
Irinotecan—CYP3A7-CYP3A51P—liver—colon cancer	0.000229	0.0124	CbGeAlD
Irinotecan—UGT1A1—liver—colon cancer	0.000222	0.0121	CbGeAlD
Irinotecan—TOP1—lymph node—colon cancer	0.000221	0.012	CbGeAlD
Irinotecan—CES1—liver—colon cancer	0.000215	0.0117	CbGeAlD
Irinotecan—CES2—lymph node—colon cancer	0.0002	0.0109	CbGeAlD
Irinotecan—ABCC2—digestive system—colon cancer	0.000188	0.0102	CbGeAlD
Irinotecan—SLCO1B1—liver—colon cancer	0.000185	0.01	CbGeAlD
Irinotecan—ABCB1—blood vessel—colon cancer	0.000183	0.00991	CbGeAlD
Irinotecan—BCHE—smooth muscle tissue—colon cancer	0.00018	0.00976	CbGeAlD
Irinotecan—SLC22A3—vagina—colon cancer	0.000177	0.00961	CbGeAlD
Irinotecan—ACHE—lymph node—colon cancer	0.000165	0.00895	CbGeAlD
Irinotecan—CES1—lymph node—colon cancer	0.000165	0.00895	CbGeAlD
Irinotecan—Osteoarthritis—Fluorouracil—colon cancer	0.00016	0.00358	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.00016	0.00358	CcSEcCtD
Irinotecan—Dehydration—Vincristine—colon cancer	0.000159	0.00357	CcSEcCtD
Irinotecan—Gait disturbance—Capecitabine—colon cancer	0.000158	0.00353	CcSEcCtD
Irinotecan—CYP3A5—renal system—colon cancer	0.000155	0.00843	CbGeAlD
Irinotecan—CYP2B6—renal system—colon cancer	0.000154	0.00837	CbGeAlD
Irinotecan—Aspartate aminotransferase increased—Vincristine—colon cancer	0.000154	0.00345	CcSEcCtD
Irinotecan—Pulmonary embolism—Capecitabine—colon cancer	0.000154	0.00344	CcSEcCtD
Irinotecan—Hiccups—Capecitabine—colon cancer	0.000154	0.00344	CcSEcCtD
Irinotecan—Phosphatase alkaline increased—Capecitabine—colon cancer	0.000154	0.00344	CcSEcCtD
Irinotecan—Cardiac arrest—Fluorouracil—colon cancer	0.000152	0.0034	CcSEcCtD
Irinotecan—ALB—liver—colon cancer	0.00015	0.00812	CbGeAlD
Irinotecan—SLC22A3—liver—colon cancer	0.000149	0.0081	CbGeAlD
Irinotecan—Colitis—Capecitabine—colon cancer	0.000148	0.00331	CcSEcCtD
Irinotecan—ABCC1—vagina—colon cancer	0.000146	0.00794	CbGeAlD
Irinotecan—BCHE—digestive system—colon cancer	0.000142	0.0077	CbGeAlD
Irinotecan—ABCC2—liver—colon cancer	0.00014	0.00761	CbGeAlD
Irinotecan—Neoplasm—Capecitabine—colon cancer	0.000139	0.00311	CcSEcCtD
Irinotecan—Neutropenia—Vincristine—colon cancer	0.000138	0.0031	CcSEcCtD
Irinotecan—Angina pectoris—Fluorouracil—colon cancer	0.000134	0.00301	CcSEcCtD
Irinotecan—Weight decreased—Vincristine—colon cancer	0.000134	0.003	CcSEcCtD
Irinotecan—Sepsis—Capecitabine—colon cancer	0.000133	0.00299	CcSEcCtD
Irinotecan—Speech disorder—Methotrexate—colon cancer	0.000133	0.00298	CcSEcCtD
Irinotecan—Pneumonia—Vincristine—colon cancer	0.000133	0.00297	CcSEcCtD
Irinotecan—Extravasation—Methotrexate—colon cancer	0.000131	0.00294	CcSEcCtD
Irinotecan—BCHE—bone marrow—colon cancer	0.000131	0.0071	CbGeAlD
Irinotecan—Acute coronary syndrome—Vincristine—colon cancer	0.00013	0.00291	CcSEcCtD
Irinotecan—Myocardial infarction—Vincristine—colon cancer	0.000129	0.0029	CcSEcCtD
Irinotecan—Thrombophlebitis—Capecitabine—colon cancer	0.000129	0.00289	CcSEcCtD
Irinotecan—Stomatitis—Vincristine—colon cancer	0.000129	0.00288	CcSEcCtD
Irinotecan—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.000128	0.00287	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Fluorouracil—colon cancer	0.000128	0.00287	CcSEcCtD
Irinotecan—CYP2B6—lymphoid tissue—colon cancer	0.000128	0.00695	CbGeAlD
Irinotecan—CYP3A5—digestive system—colon cancer	0.000127	0.00691	CbGeAlD
Irinotecan—CYP2B6—digestive system—colon cancer	0.000127	0.00687	CbGeAlD
Irinotecan—Sweating—Vincristine—colon cancer	0.000126	0.00283	CcSEcCtD
Irinotecan—ABCG2—bone marrow—colon cancer	0.000126	0.00686	CbGeAlD
Irinotecan—Hyperbilirubinaemia—Methotrexate—colon cancer	0.000126	0.00282	CcSEcCtD
Irinotecan—BCHE—vagina—colon cancer	0.000125	0.0068	CbGeAlD
Irinotecan—Pneumonia—Fluorouracil—colon cancer	0.000124	0.00277	CcSEcCtD
Irinotecan—ABCC1—liver—colon cancer	0.000123	0.0067	CbGeAlD
Irinotecan—Acute coronary syndrome—Fluorouracil—colon cancer	0.000121	0.00272	CcSEcCtD
Irinotecan—ABCG2—vagina—colon cancer	0.000121	0.00658	CbGeAlD
Irinotecan—Ulcer—Methotrexate—colon cancer	0.000121	0.00271	CcSEcCtD
Irinotecan—Dysarthria—Methotrexate—colon cancer	0.000121	0.00271	CcSEcCtD
Irinotecan—Renal failure acute—Capecitabine—colon cancer	0.000121	0.00271	CcSEcCtD
Irinotecan—Myocardial infarction—Fluorouracil—colon cancer	0.000121	0.0027	CcSEcCtD
Irinotecan—Stomatitis—Fluorouracil—colon cancer	0.00012	0.00269	CcSEcCtD
Irinotecan—Dermatitis exfoliative—Capecitabine—colon cancer	0.000118	0.00265	CcSEcCtD
Irinotecan—Renal impairment—Capecitabine—colon cancer	0.000117	0.00263	CcSEcCtD
Irinotecan—CYP3A4—renal system—colon cancer	0.000117	0.00632	CbGeAlD
Irinotecan—Connective tissue disorder—Vincristine—colon cancer	0.000116	0.00261	CcSEcCtD
Irinotecan—ALB—lymph node—colon cancer	0.000115	0.00622	CbGeAlD
Irinotecan—SLC22A3—lymph node—colon cancer	0.000115	0.00621	CbGeAlD
Irinotecan—Pulmonary embolism—Methotrexate—colon cancer	0.000114	0.00256	CcSEcCtD
Irinotecan—Cerebrovascular accident—Capecitabine—colon cancer	0.000114	0.00255	CcSEcCtD
Irinotecan—CYP3A5—vagina—colon cancer	0.000112	0.0061	CbGeAlD
Irinotecan—Hyponatraemia—Capecitabine—colon cancer	0.000112	0.00251	CcSEcCtD
Irinotecan—CYP2B6—vagina—colon cancer	0.000112	0.00607	CbGeAlD
Irinotecan—Osteoarthritis—Capecitabine—colon cancer	0.000112	0.0025	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000112	0.0025	CcSEcCtD
Irinotecan—Haemoglobin—Fluorouracil—colon cancer	0.000111	0.00249	CcSEcCtD
Irinotecan—Rhinitis—Fluorouracil—colon cancer	0.000111	0.00248	CcSEcCtD
Irinotecan—Haemorrhage—Fluorouracil—colon cancer	0.00011	0.00247	CcSEcCtD
Irinotecan—Cardiac disorder—Vincristine—colon cancer	0.00011	0.00246	CcSEcCtD
Irinotecan—ABCB1—embryo—colon cancer	0.000109	0.00591	CbGeAlD
Irinotecan—ABCC2—lymph node—colon cancer	0.000107	0.00583	CbGeAlD
Irinotecan—Angiopathy—Vincristine—colon cancer	0.000107	0.00241	CcSEcCtD
Irinotecan—Mediastinal disorder—Vincristine—colon cancer	0.000107	0.00239	CcSEcCtD
Irinotecan—Cardiac arrest—Capecitabine—colon cancer	0.000106	0.00238	CcSEcCtD
Irinotecan—BCHE—liver—colon cancer	0.000106	0.00574	CbGeAlD
Irinotecan—Alopecia—Vincristine—colon cancer	0.000105	0.00234	CcSEcCtD
Irinotecan—Blood creatinine increased—Capecitabine—colon cancer	0.000105	0.00234	CcSEcCtD
Irinotecan—Dehydration—Capecitabine—colon cancer	0.000104	0.00232	CcSEcCtD
Irinotecan—Neoplasm—Methotrexate—colon cancer	0.000103	0.00232	CcSEcCtD
Irinotecan—ABCG2—liver—colon cancer	0.000102	0.00555	CbGeAlD
Irinotecan—Orthostatic hypotension—Capecitabine—colon cancer	0.000102	0.00228	CcSEcCtD
Irinotecan—Hypokalaemia—Capecitabine—colon cancer	0.000102	0.00227	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.0001	0.00225	CcSEcCtD
Irinotecan—Back pain—Vincristine—colon cancer	9.97e-05	0.00223	CcSEcCtD
Irinotecan—Sepsis—Methotrexate—colon cancer	9.93e-05	0.00222	CcSEcCtD
Irinotecan—Arrhythmia—Fluorouracil—colon cancer	9.87e-05	0.00221	CcSEcCtD
Irinotecan—Alopecia—Fluorouracil—colon cancer	9.76e-05	0.00219	CcSEcCtD
Irinotecan—Abdominal distension—Capecitabine—colon cancer	9.71e-05	0.00217	CcSEcCtD
Irinotecan—Thrombophlebitis—Methotrexate—colon cancer	9.6e-05	0.00215	CcSEcCtD
Irinotecan—CYP3A4—digestive system—colon cancer	9.56e-05	0.00519	CbGeAlD
Irinotecan—Anaemia—Vincristine—colon cancer	9.53e-05	0.00213	CcSEcCtD
Irinotecan—CYP3A5—liver—colon cancer	9.49e-05	0.00515	CbGeAlD
Irinotecan—ABCC1—lymph node—colon cancer	9.47e-05	0.00514	CbGeAlD
Irinotecan—CYP2B6—liver—colon cancer	9.43e-05	0.00512	CbGeAlD
Irinotecan—Sweating increased—Capecitabine—colon cancer	9.4e-05	0.0021	CcSEcCtD
Irinotecan—Angina pectoris—Capecitabine—colon cancer	9.4e-05	0.0021	CcSEcCtD
Irinotecan—Vertigo—Vincristine—colon cancer	9.26e-05	0.00207	CcSEcCtD
Irinotecan—Leukopenia—Vincristine—colon cancer	9.23e-05	0.00207	CcSEcCtD
Irinotecan—Neutropenia—Capecitabine—colon cancer	9.02e-05	0.00202	CcSEcCtD
Irinotecan—Renal failure acute—Methotrexate—colon cancer	9e-05	0.00201	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Capecitabine—colon cancer	8.96e-05	0.00201	CcSEcCtD
Irinotecan—Hypertension—Vincristine—colon cancer	8.9e-05	0.00199	CcSEcCtD
Irinotecan—ABCB1—epithelium—colon cancer	8.89e-05	0.00483	CbGeAlD
Irinotecan—Anaemia—Fluorouracil—colon cancer	8.89e-05	0.00199	CcSEcCtD
Irinotecan—Dermatitis exfoliative—Methotrexate—colon cancer	8.8e-05	0.00197	CcSEcCtD
Irinotecan—Visual disturbance—Methotrexate—colon cancer	8.77e-05	0.00196	CcSEcCtD
Irinotecan—Weight decreased—Capecitabine—colon cancer	8.73e-05	0.00195	CcSEcCtD
Irinotecan—Pneumonia—Capecitabine—colon cancer	8.65e-05	0.00194	CcSEcCtD
Irinotecan—Leukopenia—Fluorouracil—colon cancer	8.61e-05	0.00193	CcSEcCtD
Irinotecan—Anaphylactoid reaction—Methotrexate—colon cancer	8.58e-05	0.00192	CcSEcCtD
Irinotecan—Acute coronary syndrome—Capecitabine—colon cancer	8.48e-05	0.0019	CcSEcCtD
Irinotecan—Cerebrovascular accident—Methotrexate—colon cancer	8.48e-05	0.0019	CcSEcCtD
Irinotecan—Renal failure—Capecitabine—colon cancer	8.45e-05	0.00189	CcSEcCtD
Irinotecan—Myocardial infarction—Capecitabine—colon cancer	8.43e-05	0.00189	CcSEcCtD
Irinotecan—Anaphylactic shock—Vincristine—colon cancer	8.41e-05	0.00188	CcSEcCtD
Irinotecan—Oedema—Vincristine—colon cancer	8.41e-05	0.00188	CcSEcCtD
Irinotecan—Jaundice—Capecitabine—colon cancer	8.38e-05	0.00188	CcSEcCtD
Irinotecan—Stomatitis—Capecitabine—colon cancer	8.38e-05	0.00188	CcSEcCtD
Irinotecan—Infection—Vincristine—colon cancer	8.36e-05	0.00187	CcSEcCtD
Irinotecan—Osteoarthritis—Methotrexate—colon cancer	8.31e-05	0.00186	CcSEcCtD
Irinotecan—Nervous system disorder—Vincristine—colon cancer	8.25e-05	0.00185	CcSEcCtD
Irinotecan—ABCB1—renal system—colon cancer	8.25e-05	0.00448	CbGeAlD
Irinotecan—Thrombocytopenia—Vincristine—colon cancer	8.24e-05	0.00184	CcSEcCtD
Irinotecan—Hyperhidrosis—Vincristine—colon cancer	8.13e-05	0.00182	CcSEcCtD
Irinotecan—BCHE—lymph node—colon cancer	8.11e-05	0.0044	CbGeAlD
Irinotecan—Discomfort—Fluorouracil—colon cancer	8.09e-05	0.00181	CcSEcCtD
Irinotecan—Anorexia—Vincristine—colon cancer	8.02e-05	0.0018	CcSEcCtD
Irinotecan—Confusional state—Fluorouracil—colon cancer	7.91e-05	0.00177	CcSEcCtD
Irinotecan—Hypotension—Vincristine—colon cancer	7.86e-05	0.00176	CcSEcCtD
Irinotecan—Bradycardia—Capecitabine—colon cancer	7.86e-05	0.00176	CcSEcCtD
Irinotecan—Oedema—Fluorouracil—colon cancer	7.85e-05	0.00176	CcSEcCtD
Irinotecan—Anaphylactic shock—Fluorouracil—colon cancer	7.85e-05	0.00176	CcSEcCtD
Irinotecan—ABCG2—lymph node—colon cancer	7.84e-05	0.00425	CbGeAlD
Irinotecan—Infection—Fluorouracil—colon cancer	7.8e-05	0.00175	CcSEcCtD
Irinotecan—Haemoglobin—Capecitabine—colon cancer	7.76e-05	0.00174	CcSEcCtD
Irinotecan—Rhinitis—Capecitabine—colon cancer	7.74e-05	0.00173	CcSEcCtD
Irinotecan—Haemorrhage—Capecitabine—colon cancer	7.72e-05	0.00173	CcSEcCtD
Irinotecan—Nervous system disorder—Fluorouracil—colon cancer	7.7e-05	0.00172	CcSEcCtD
Irinotecan—Thrombocytopenia—Fluorouracil—colon cancer	7.68e-05	0.00172	CcSEcCtD
Irinotecan—Insomnia—Vincristine—colon cancer	7.61e-05	0.0017	CcSEcCtD
Irinotecan—Connective tissue disorder—Capecitabine—colon cancer	7.59e-05	0.0017	CcSEcCtD
Irinotecan—Paraesthesia—Vincristine—colon cancer	7.56e-05	0.00169	CcSEcCtD
Irinotecan—Anorexia—Fluorouracil—colon cancer	7.48e-05	0.00168	CcSEcCtD
Irinotecan—Visual impairment—Capecitabine—colon cancer	7.44e-05	0.00167	CcSEcCtD
Irinotecan—Hypotension—Fluorouracil—colon cancer	7.33e-05	0.00164	CcSEcCtD
Irinotecan—Decreased appetite—Vincristine—colon cancer	7.31e-05	0.00164	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Vincristine—colon cancer	7.26e-05	0.00163	CcSEcCtD
Irinotecan—Fatigue—Vincristine—colon cancer	7.25e-05	0.00162	CcSEcCtD
Irinotecan—Pain—Vincristine—colon cancer	7.2e-05	0.00161	CcSEcCtD
Irinotecan—Constipation—Vincristine—colon cancer	7.2e-05	0.00161	CcSEcCtD
Irinotecan—Flushing—Capecitabine—colon cancer	7.16e-05	0.0016	CcSEcCtD
Irinotecan—Cardiac disorder—Capecitabine—colon cancer	7.16e-05	0.0016	CcSEcCtD
Irinotecan—CYP3A4—liver—colon cancer	7.12e-05	0.00386	CbGeAlD
Irinotecan—Insomnia—Fluorouracil—colon cancer	7.1e-05	0.00159	CcSEcCtD
Irinotecan—Paraesthesia—Fluorouracil—colon cancer	7.05e-05	0.00158	CcSEcCtD
Irinotecan—Pancreatitis—Methotrexate—colon cancer	7.04e-05	0.00158	CcSEcCtD
Irinotecan—Angiopathy—Capecitabine—colon cancer	7e-05	0.00157	CcSEcCtD
Irinotecan—Dyspnoea—Fluorouracil—colon cancer	7e-05	0.00157	CcSEcCtD
Irinotecan—Somnolence—Fluorouracil—colon cancer	6.98e-05	0.00156	CcSEcCtD
Irinotecan—Immune system disorder—Capecitabine—colon cancer	6.97e-05	0.00156	CcSEcCtD
Irinotecan—Mediastinal disorder—Capecitabine—colon cancer	6.96e-05	0.00156	CcSEcCtD
Irinotecan—Chills—Capecitabine—colon cancer	6.93e-05	0.00155	CcSEcCtD
Irinotecan—Dyspepsia—Fluorouracil—colon cancer	6.91e-05	0.00155	CcSEcCtD
Irinotecan—Arrhythmia—Capecitabine—colon cancer	6.9e-05	0.00154	CcSEcCtD
Irinotecan—Gastrointestinal pain—Vincristine—colon cancer	6.88e-05	0.00154	CcSEcCtD
Irinotecan—ABCB1—lymphoid tissue—colon cancer	6.85e-05	0.00372	CbGeAlD
Irinotecan—Decreased appetite—Fluorouracil—colon cancer	6.82e-05	0.00153	CcSEcCtD
Irinotecan—Alopecia—Capecitabine—colon cancer	6.82e-05	0.00153	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Fluorouracil—colon cancer	6.78e-05	0.00152	CcSEcCtD
Irinotecan—ABCB1—digestive system—colon cancer	6.77e-05	0.00367	CbGeAlD
Irinotecan—Neutropenia—Methotrexate—colon cancer	6.71e-05	0.0015	CcSEcCtD
Irinotecan—Pain—Fluorouracil—colon cancer	6.71e-05	0.0015	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Methotrexate—colon cancer	6.67e-05	0.00149	CcSEcCtD
Irinotecan—Abdominal pain—Vincristine—colon cancer	6.65e-05	0.00149	CcSEcCtD
Irinotecan—Body temperature increased—Vincristine—colon cancer	6.65e-05	0.00149	CcSEcCtD
Irinotecan—Flatulence—Capecitabine—colon cancer	6.62e-05	0.00148	CcSEcCtD
Irinotecan—Back pain—Capecitabine—colon cancer	6.5e-05	0.00146	CcSEcCtD
Irinotecan—Feeling abnormal—Fluorouracil—colon cancer	6.47e-05	0.00145	CcSEcCtD
Irinotecan—Muscle spasms—Capecitabine—colon cancer	6.46e-05	0.00145	CcSEcCtD
Irinotecan—Pneumonia—Methotrexate—colon cancer	6.44e-05	0.00144	CcSEcCtD
Irinotecan—Renal failure—Methotrexate—colon cancer	6.29e-05	0.00141	CcSEcCtD
Irinotecan—Stomatitis—Methotrexate—colon cancer	6.24e-05	0.0014	CcSEcCtD
Irinotecan—ABCB1—bone marrow—colon cancer	6.24e-05	0.00338	CbGeAlD
Irinotecan—Ill-defined disorder—Capecitabine—colon cancer	6.24e-05	0.0014	CcSEcCtD
Irinotecan—Anaemia—Capecitabine—colon cancer	6.21e-05	0.00139	CcSEcCtD
Irinotecan—Body temperature increased—Fluorouracil—colon cancer	6.2e-05	0.00139	CcSEcCtD
Irinotecan—Hypersensitivity—Vincristine—colon cancer	6.2e-05	0.00139	CcSEcCtD
Irinotecan—Sweating—Methotrexate—colon cancer	6.14e-05	0.00137	CcSEcCtD
Irinotecan—Malaise—Capecitabine—colon cancer	6.06e-05	0.00136	CcSEcCtD
Irinotecan—Vertigo—Capecitabine—colon cancer	6.04e-05	0.00135	CcSEcCtD
Irinotecan—Asthenia—Vincristine—colon cancer	6.04e-05	0.00135	CcSEcCtD
Irinotecan—Syncope—Capecitabine—colon cancer	6.03e-05	0.00135	CcSEcCtD
Irinotecan—Leukopenia—Capecitabine—colon cancer	6.02e-05	0.00135	CcSEcCtD
Irinotecan—ABCB1—vagina—colon cancer	5.98e-05	0.00324	CbGeAlD
Irinotecan—Loss of consciousness—Capecitabine—colon cancer	5.91e-05	0.00132	CcSEcCtD
Irinotecan—Cough—Capecitabine—colon cancer	5.86e-05	0.00131	CcSEcCtD
Irinotecan—Hypertension—Capecitabine—colon cancer	5.8e-05	0.0013	CcSEcCtD
Irinotecan—Hypersensitivity—Fluorouracil—colon cancer	5.78e-05	0.00129	CcSEcCtD
Irinotecan—Haemoglobin—Methotrexate—colon cancer	5.78e-05	0.00129	CcSEcCtD
Irinotecan—Diarrhoea—Vincristine—colon cancer	5.76e-05	0.00129	CcSEcCtD
Irinotecan—Haemorrhage—Methotrexate—colon cancer	5.75e-05	0.00129	CcSEcCtD
Irinotecan—Discomfort—Capecitabine—colon cancer	5.65e-05	0.00127	CcSEcCtD
Irinotecan—Dizziness—Vincristine—colon cancer	5.56e-05	0.00125	CcSEcCtD
Irinotecan—Visual impairment—Methotrexate—colon cancer	5.54e-05	0.00124	CcSEcCtD
Irinotecan—Confusional state—Capecitabine—colon cancer	5.53e-05	0.00124	CcSEcCtD
Irinotecan—Oedema—Capecitabine—colon cancer	5.48e-05	0.00123	CcSEcCtD
Irinotecan—Infection—Capecitabine—colon cancer	5.45e-05	0.00122	CcSEcCtD
Irinotecan—Shock—Capecitabine—colon cancer	5.4e-05	0.00121	CcSEcCtD
Irinotecan—Nervous system disorder—Capecitabine—colon cancer	5.38e-05	0.0012	CcSEcCtD
Irinotecan—Diarrhoea—Fluorouracil—colon cancer	5.37e-05	0.0012	CcSEcCtD
Irinotecan—Thrombocytopenia—Capecitabine—colon cancer	5.37e-05	0.0012	CcSEcCtD
Irinotecan—Vomiting—Vincristine—colon cancer	5.35e-05	0.0012	CcSEcCtD
Irinotecan—Cardiac disorder—Methotrexate—colon cancer	5.33e-05	0.00119	CcSEcCtD
Irinotecan—Rash—Vincristine—colon cancer	5.31e-05	0.00119	CcSEcCtD
Irinotecan—Hyperhidrosis—Capecitabine—colon cancer	5.3e-05	0.00119	CcSEcCtD
Irinotecan—Dermatitis—Vincristine—colon cancer	5.3e-05	0.00119	CcSEcCtD
Irinotecan—Headache—Vincristine—colon cancer	5.27e-05	0.00118	CcSEcCtD
Irinotecan—Anorexia—Capecitabine—colon cancer	5.23e-05	0.00117	CcSEcCtD
Irinotecan—Angiopathy—Methotrexate—colon cancer	5.21e-05	0.00117	CcSEcCtD
Irinotecan—Immune system disorder—Methotrexate—colon cancer	5.19e-05	0.00116	CcSEcCtD
Irinotecan—Dizziness—Fluorouracil—colon cancer	5.19e-05	0.00116	CcSEcCtD
Irinotecan—Mediastinal disorder—Methotrexate—colon cancer	5.18e-05	0.00116	CcSEcCtD
Irinotecan—Chills—Methotrexate—colon cancer	5.16e-05	0.00115	CcSEcCtD
Irinotecan—Hypotension—Capecitabine—colon cancer	5.13e-05	0.00115	CcSEcCtD
Irinotecan—Alopecia—Methotrexate—colon cancer	5.08e-05	0.00114	CcSEcCtD
Irinotecan—ABCB1—liver—colon cancer	5.04e-05	0.00274	CbGeAlD
Irinotecan—Nausea—Vincristine—colon cancer	5e-05	0.00112	CcSEcCtD
Irinotecan—Vomiting—Fluorouracil—colon cancer	4.99e-05	0.00112	CcSEcCtD
Irinotecan—Insomnia—Capecitabine—colon cancer	4.96e-05	0.00111	CcSEcCtD
Irinotecan—Rash—Fluorouracil—colon cancer	4.95e-05	0.00111	CcSEcCtD
Irinotecan—Dermatitis—Fluorouracil—colon cancer	4.94e-05	0.00111	CcSEcCtD
Irinotecan—Paraesthesia—Capecitabine—colon cancer	4.93e-05	0.0011	CcSEcCtD
Irinotecan—Headache—Fluorouracil—colon cancer	4.92e-05	0.0011	CcSEcCtD
Irinotecan—Dyspnoea—Capecitabine—colon cancer	4.89e-05	0.00109	CcSEcCtD
Irinotecan—Back pain—Methotrexate—colon cancer	4.84e-05	0.00108	CcSEcCtD
Irinotecan—Dyspepsia—Capecitabine—colon cancer	4.83e-05	0.00108	CcSEcCtD
Irinotecan—Decreased appetite—Capecitabine—colon cancer	4.77e-05	0.00107	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Capecitabine—colon cancer	4.74e-05	0.00106	CcSEcCtD
Irinotecan—Fatigue—Capecitabine—colon cancer	4.73e-05	0.00106	CcSEcCtD
Irinotecan—Constipation—Capecitabine—colon cancer	4.69e-05	0.00105	CcSEcCtD
Irinotecan—Pain—Capecitabine—colon cancer	4.69e-05	0.00105	CcSEcCtD
Irinotecan—Nausea—Fluorouracil—colon cancer	4.66e-05	0.00104	CcSEcCtD
Irinotecan—Ill-defined disorder—Methotrexate—colon cancer	4.64e-05	0.00104	CcSEcCtD
Irinotecan—Anaemia—Methotrexate—colon cancer	4.62e-05	0.00104	CcSEcCtD
Irinotecan—Feeling abnormal—Capecitabine—colon cancer	4.52e-05	0.00101	CcSEcCtD
Irinotecan—Malaise—Methotrexate—colon cancer	4.51e-05	0.00101	CcSEcCtD
Irinotecan—Vertigo—Methotrexate—colon cancer	4.49e-05	0.00101	CcSEcCtD
Irinotecan—Gastrointestinal pain—Capecitabine—colon cancer	4.49e-05	0.001	CcSEcCtD
Irinotecan—Leukopenia—Methotrexate—colon cancer	4.48e-05	0.001	CcSEcCtD
Irinotecan—Cough—Methotrexate—colon cancer	4.37e-05	0.000978	CcSEcCtD
Irinotecan—Abdominal pain—Capecitabine—colon cancer	4.34e-05	0.000971	CcSEcCtD
Irinotecan—Body temperature increased—Capecitabine—colon cancer	4.34e-05	0.000971	CcSEcCtD
Irinotecan—Discomfort—Methotrexate—colon cancer	4.21e-05	0.000942	CcSEcCtD
Irinotecan—Confusional state—Methotrexate—colon cancer	4.12e-05	0.000922	CcSEcCtD
Irinotecan—Anaphylactic shock—Methotrexate—colon cancer	4.08e-05	0.000914	CcSEcCtD
Irinotecan—Infection—Methotrexate—colon cancer	4.06e-05	0.000908	CcSEcCtD
Irinotecan—Hypersensitivity—Capecitabine—colon cancer	4.04e-05	0.000905	CcSEcCtD
Irinotecan—Nervous system disorder—Methotrexate—colon cancer	4e-05	0.000897	CcSEcCtD
Irinotecan—Thrombocytopenia—Methotrexate—colon cancer	4e-05	0.000895	CcSEcCtD
Irinotecan—Hyperhidrosis—Methotrexate—colon cancer	3.95e-05	0.000884	CcSEcCtD
Irinotecan—Asthenia—Capecitabine—colon cancer	3.94e-05	0.000881	CcSEcCtD
Irinotecan—Anorexia—Methotrexate—colon cancer	3.89e-05	0.000871	CcSEcCtD
Irinotecan—ABCB1—lymph node—colon cancer	3.86e-05	0.0021	CbGeAlD
Irinotecan—Hypotension—Methotrexate—colon cancer	3.82e-05	0.000854	CcSEcCtD
Irinotecan—Diarrhoea—Capecitabine—colon cancer	3.75e-05	0.00084	CcSEcCtD
Irinotecan—Insomnia—Methotrexate—colon cancer	3.69e-05	0.000827	CcSEcCtD
Irinotecan—Paraesthesia—Methotrexate—colon cancer	3.67e-05	0.000821	CcSEcCtD
Irinotecan—Dyspnoea—Methotrexate—colon cancer	3.64e-05	0.000815	CcSEcCtD
Irinotecan—Somnolence—Methotrexate—colon cancer	3.63e-05	0.000813	CcSEcCtD
Irinotecan—Dizziness—Capecitabine—colon cancer	3.63e-05	0.000812	CcSEcCtD
Irinotecan—Dyspepsia—Methotrexate—colon cancer	3.59e-05	0.000805	CcSEcCtD
Irinotecan—Decreased appetite—Methotrexate—colon cancer	3.55e-05	0.000795	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Methotrexate—colon cancer	3.53e-05	0.000789	CcSEcCtD
Irinotecan—Fatigue—Methotrexate—colon cancer	3.52e-05	0.000788	CcSEcCtD
Irinotecan—Pain—Methotrexate—colon cancer	3.49e-05	0.000782	CcSEcCtD
Irinotecan—Vomiting—Capecitabine—colon cancer	3.49e-05	0.000781	CcSEcCtD
Irinotecan—Rash—Capecitabine—colon cancer	3.46e-05	0.000774	CcSEcCtD
Irinotecan—Dermatitis—Capecitabine—colon cancer	3.46e-05	0.000774	CcSEcCtD
Irinotecan—Headache—Capecitabine—colon cancer	3.44e-05	0.000769	CcSEcCtD
Irinotecan—Feeling abnormal—Methotrexate—colon cancer	3.36e-05	0.000753	CcSEcCtD
Irinotecan—Gastrointestinal pain—Methotrexate—colon cancer	3.34e-05	0.000748	CcSEcCtD
Irinotecan—Nausea—Capecitabine—colon cancer	3.26e-05	0.000729	CcSEcCtD
Irinotecan—Abdominal pain—Methotrexate—colon cancer	3.23e-05	0.000723	CcSEcCtD
Irinotecan—Body temperature increased—Methotrexate—colon cancer	3.23e-05	0.000723	CcSEcCtD
Irinotecan—Hypersensitivity—Methotrexate—colon cancer	3.01e-05	0.000674	CcSEcCtD
Irinotecan—Asthenia—Methotrexate—colon cancer	2.93e-05	0.000656	CcSEcCtD
Irinotecan—Diarrhoea—Methotrexate—colon cancer	2.79e-05	0.000626	CcSEcCtD
Irinotecan—Dizziness—Methotrexate—colon cancer	2.7e-05	0.000605	CcSEcCtD
Irinotecan—Vomiting—Methotrexate—colon cancer	2.6e-05	0.000581	CcSEcCtD
Irinotecan—Rash—Methotrexate—colon cancer	2.57e-05	0.000576	CcSEcCtD
Irinotecan—Dermatitis—Methotrexate—colon cancer	2.57e-05	0.000576	CcSEcCtD
Irinotecan—Headache—Methotrexate—colon cancer	2.56e-05	0.000573	CcSEcCtD
Irinotecan—Nausea—Methotrexate—colon cancer	2.43e-05	0.000543	CcSEcCtD
Irinotecan—UGT1A9—Metabolism—CHST5—colon cancer	2.08e-05	0.00112	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ODC1—colon cancer	2.08e-05	0.00112	CbGpPWpGaD
Irinotecan—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	2.05e-05	0.00111	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—BRAF—colon cancer	2.03e-05	0.0011	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ODC1—colon cancer	2e-05	0.00108	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CHST5—colon cancer	2e-05	0.00108	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CHST5—colon cancer	1.95e-05	0.00106	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ODC1—colon cancer	1.95e-05	0.00106	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ODC1—colon cancer	1.9e-05	0.00103	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CHST5—colon cancer	1.9e-05	0.00103	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—BRAF—colon cancer	1.81e-05	0.00098	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CA7—colon cancer	1.8e-05	0.00097	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ODC1—colon cancer	1.76e-05	0.000953	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CHST5—colon cancer	1.76e-05	0.000953	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ODC1—colon cancer	1.75e-05	0.000944	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CHST5—colon cancer	1.75e-05	0.000944	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	1.74e-05	0.000938	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AXIN2—colon cancer	1.72e-05	0.000929	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.7e-05	0.00092	CbGpPWpGaD
Irinotecan—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.61e-05	0.000871	CbGpPWpGaD
Irinotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	1.6e-05	0.000862	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.58e-05	0.000854	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CA7—colon cancer	1.57e-05	0.00085	CbGpPWpGaD
Irinotecan—ALB—Selenium Micronutrient Network—PTGS2—colon cancer	1.57e-05	0.00085	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—ABCB1—colon cancer	1.57e-05	0.000848	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—BRAF—colon cancer	1.56e-05	0.000841	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.54e-05	0.000832	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.52e-05	0.000823	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.49e-05	0.000804	CbGpPWpGaD
Irinotecan—UGT1A1—NRF2 pathway—TGFB1—colon cancer	1.45e-05	0.000783	CbGpPWpGaD
Irinotecan—UGT1A9—NRF2 pathway—TGFB1—colon cancer	1.45e-05	0.000783	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	1.44e-05	0.00078	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.42e-05	0.000765	CbGpPWpGaD
Irinotecan—ABCC2—NRF2 pathway—TGFB1—colon cancer	1.41e-05	0.000764	CbGpPWpGaD
Irinotecan—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	1.41e-05	0.000762	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—CASP3—colon cancer	1.39e-05	0.000754	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—BRAF—colon cancer	1.39e-05	0.000751	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.38e-05	0.000744	CbGpPWpGaD
Irinotecan—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	1.38e-05	0.000744	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	1.37e-05	0.000738	CbGpPWpGaD
Irinotecan—ACHE—Phospholipid metabolism—PIK3CA—colon cancer	1.36e-05	0.000734	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.34e-05	0.000725	CbGpPWpGaD
Irinotecan—ALB—Platelet degranulation—VEGFA—colon cancer	1.34e-05	0.000722	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	1.33e-05	0.000719	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CHST5—colon cancer	1.29e-05	0.000698	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ODC1—colon cancer	1.29e-05	0.000698	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	1.28e-05	0.000692	CbGpPWpGaD
Irinotecan—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	1.27e-05	0.000688	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ODC1—colon cancer	1.26e-05	0.000683	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CHST5—colon cancer	1.26e-05	0.000683	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.23e-05	0.000667	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.23e-05	0.000665	CbGpPWpGaD
Irinotecan—ALB—Platelet degranulation—TGFB1—colon cancer	1.23e-05	0.000663	CbGpPWpGaD
Irinotecan—BCHE—Phospholipid metabolism—PIK3CA—colon cancer	1.21e-05	0.000655	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.21e-05	0.000652	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—VEGFA—colon cancer	1.18e-05	0.000639	CbGpPWpGaD
Irinotecan—ALB—Folate Metabolism—TP53—colon cancer	1.18e-05	0.000637	CbGpPWpGaD
Irinotecan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	1.17e-05	0.000632	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.14e-05	0.000618	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.14e-05	0.000616	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—ABCB1—colon cancer	1.13e-05	0.000611	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ODC1—colon cancer	1.09e-05	0.000588	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CHST5—colon cancer	1.09e-05	0.000588	CbGpPWpGaD
Irinotecan—ABCB1—Allograft Rejection—TGFB1—colon cancer	1.09e-05	0.000587	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—ABCB1—colon cancer	1.07e-05	0.000581	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.05e-05	0.000566	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.01e-05	0.000548	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	9.95e-06	0.000538	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	9.76e-06	0.000528	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CA7—colon cancer	9.69e-06	0.000524	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CHST5—colon cancer	9.53e-06	0.000515	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ODC1—colon cancer	9.53e-06	0.000515	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—HRAS—colon cancer	9.34e-06	0.000505	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.04e-06	0.000489	CbGpPWpGaD
Irinotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	8.72e-06	0.000471	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.58e-06	0.000464	CbGpPWpGaD
Irinotecan—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	8.56e-06	0.000463	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—HRAS—colon cancer	8.34e-06	0.00045	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.27e-06	0.000447	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.06e-06	0.000436	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.86e-06	0.000425	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	7.41e-06	0.000401	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—ABCB1—colon cancer	7.35e-06	0.000397	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—TYMS—colon cancer	7.22e-06	0.00039	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—HRAS—colon cancer	7.16e-06	0.000387	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.11e-06	0.000384	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	6.88e-06	0.000372	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.75e-06	0.000365	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	6.7e-06	0.000362	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	6.63e-06	0.000358	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.51e-06	0.000352	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	6.48e-06	0.00035	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—HRAS—colon cancer	6.39e-06	0.000345	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.34e-06	0.000343	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.18e-06	0.000334	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	6.17e-06	0.000333	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	6.14e-06	0.000332	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	6.09e-06	0.000329	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	6e-06	0.000324	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	5.93e-06	0.00032	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.91e-06	0.00032	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CHST5—colon cancer	5.87e-06	0.000317	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ODC1—colon cancer	5.87e-06	0.000317	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	5.84e-06	0.000316	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ABCB1—colon cancer	5.79e-06	0.000313	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—TYMS—colon cancer	5.68e-06	0.000307	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.61e-06	0.000303	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of proteins—CTNNB1—colon cancer	5.5e-06	0.000297	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ABCB1—colon cancer	5.49e-06	0.000297	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ABCB1—colon cancer	5.49e-06	0.000297	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	5.44e-06	0.000294	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.41e-06	0.000292	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—TYMS—colon cancer	5.39e-06	0.000291	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—TYMS—colon cancer	5.39e-06	0.000291	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	5.37e-06	0.00029	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	5.36e-06	0.00029	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ABCB1—colon cancer	5.29e-06	0.000286	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.28e-06	0.000285	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	5.25e-06	0.000284	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—TYMS—colon cancer	5.2e-06	0.000281	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ABCB1—colon cancer	5.16e-06	0.000279	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.14e-06	0.000278	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PPARG—colon cancer	5.11e-06	0.000276	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—TYMS—colon cancer	5.07e-06	0.000274	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ABCB1—colon cancer	5.03e-06	0.000272	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	4.96e-06	0.000268	CbGpPWpGaD
Irinotecan—ABCC1—Disease—FGFR3—colon cancer	4.96e-06	0.000268	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—TYMS—colon cancer	4.94e-06	0.000267	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of proteins—CTNNB1—colon cancer	4.91e-06	0.000265	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ABCB1—colon cancer	4.66e-06	0.000252	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	4.63e-06	0.00025	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ABCB1—colon cancer	4.62e-06	0.00025	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—TYMS—colon cancer	4.58e-06	0.000247	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	4.56e-06	0.000246	CbGpPWpGaD
Irinotecan—ABCC1—Disease—APC—colon cancer	4.56e-06	0.000246	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—TYMS—colon cancer	4.54e-06	0.000245	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.49e-06	0.000243	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	4.41e-06	0.000238	CbGpPWpGaD
Irinotecan—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.38e-06	0.000236	CbGpPWpGaD
Irinotecan—ABCC1—Disease—BRAF—colon cancer	4.28e-06	0.000231	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.15e-06	0.000224	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PPARG—colon cancer	4.03e-06	0.000218	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTGS2—colon cancer	4.02e-06	0.000217	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4e-06	0.000216	CbGpPWpGaD
Irinotecan—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.9e-06	0.000211	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PPARG—colon cancer	3.82e-06	0.000206	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PPARG—colon cancer	3.82e-06	0.000206	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.8e-06	0.000206	CbGpPWpGaD
Irinotecan—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	3.78e-06	0.000204	CbGpPWpGaD
Irinotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	3.73e-06	0.000201	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PPARG—colon cancer	3.68e-06	0.000199	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PPARG—colon cancer	3.59e-06	0.000194	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.53e-06	0.000191	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PPARG—colon cancer	3.5e-06	0.000189	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTGS2—colon cancer	3.46e-06	0.000187	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ABCB1—colon cancer	3.42e-06	0.000185	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—TYMS—colon cancer	3.35e-06	0.000181	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—EP300—colon cancer	3.35e-06	0.000181	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ABCB1—colon cancer	3.34e-06	0.00018	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—TYMS—colon cancer	3.28e-06	0.000177	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PPARG—colon cancer	3.24e-06	0.000175	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—EP300—colon cancer	3.23e-06	0.000174	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PPARG—colon cancer	3.21e-06	0.000174	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTGS2—colon cancer	3.17e-06	0.000171	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—SRC—colon cancer	3.14e-06	0.00017	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CTNNB1—colon cancer	3.1e-06	0.000167	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—colon cancer	3.06e-06	0.000165	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1A—colon cancer	3.02e-06	0.000163	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—NRAS—colon cancer	3.02e-06	0.000163	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTGS2—colon cancer	3.01e-06	0.000162	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTGS2—colon cancer	3.01e-06	0.000162	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.94e-06	0.000159	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTGS2—colon cancer	2.9e-06	0.000157	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EP300—colon cancer	2.88e-06	0.000156	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ABCB1—colon cancer	2.87e-06	0.000155	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTGS2—colon cancer	2.83e-06	0.000153	CbGpPWpGaD
Irinotecan—ALB—Metabolism—TYMS—colon cancer	2.82e-06	0.000153	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TGFB1—colon cancer	2.81e-06	0.000152	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SRC—colon cancer	2.8e-06	0.000151	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTGS2—colon cancer	2.75e-06	0.000149	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NRAS—colon cancer	2.69e-06	0.000145	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—EP300—colon cancer	2.63e-06	0.000142	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—KRAS—colon cancer	2.6e-06	0.00014	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTGS2—colon cancer	2.55e-06	0.000138	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTGS2—colon cancer	2.53e-06	0.000137	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MYC—colon cancer	2.51e-06	0.000136	CbGpPWpGaD
Irinotecan—ABCC1—Disease—TGFB1—colon cancer	2.5e-06	0.000135	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—EP300—colon cancer	2.5e-06	0.000135	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—EP300—colon cancer	2.5e-06	0.000135	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CA—colon cancer	2.48e-06	0.000134	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—TYMS—colon cancer	2.47e-06	0.000134	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EGFR—colon cancer	2.45e-06	0.000133	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—EP300—colon cancer	2.41e-06	0.00013	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CA—colon cancer	2.39e-06	0.000129	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PPARG—colon cancer	2.38e-06	0.000128	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—EP300—colon cancer	2.35e-06	0.000127	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PPARG—colon cancer	2.32e-06	0.000126	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KRAS—colon cancer	2.32e-06	0.000125	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—colon cancer	2.31e-06	0.000125	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—EP300—colon cancer	2.29e-06	0.000124	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HRAS—colon cancer	2.21e-06	0.000119	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.17e-06	0.000117	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CA—colon cancer	2.13e-06	0.000115	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—EP300—colon cancer	2.12e-06	0.000115	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—EP300—colon cancer	2.1e-06	0.000114	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AKT1—colon cancer	2.02e-06	0.000109	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PPARG—colon cancer	2e-06	0.000108	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HRAS—colon cancer	1.97e-06	0.000106	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—AKT1—colon cancer	1.95e-06	0.000105	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CA—colon cancer	1.95e-06	0.000105	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS2—colon cancer	1.87e-06	0.000101	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CA—colon cancer	1.85e-06	9.99e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CA—colon cancer	1.85e-06	9.99e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS2—colon cancer	1.83e-06	9.87e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CA—colon cancer	1.78e-06	9.63e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PPARG—colon cancer	1.75e-06	9.47e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKT1—colon cancer	1.74e-06	9.4e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CA—colon cancer	1.74e-06	9.39e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CA—colon cancer	1.69e-06	9.16e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AKT1—colon cancer	1.59e-06	8.6e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS2—colon cancer	1.57e-06	8.5e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CA—colon cancer	1.57e-06	8.48e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CA—colon cancer	1.55e-06	8.4e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—EP300—colon cancer	1.55e-06	8.4e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ABCB1—colon cancer	1.55e-06	8.39e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TYMS—colon cancer	1.52e-06	8.24e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—EP300—colon cancer	1.52e-06	8.21e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AKT1—colon cancer	1.51e-06	8.16e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AKT1—colon cancer	1.51e-06	8.16e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AKT1—colon cancer	1.46e-06	7.87e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AKT1—colon cancer	1.42e-06	7.67e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKT1—colon cancer	1.38e-06	7.48e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS2—colon cancer	1.38e-06	7.45e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—EP300—colon cancer	1.31e-06	7.07e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKT1—colon cancer	1.28e-06	6.93e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKT1—colon cancer	1.27e-06	6.86e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CA—colon cancer	1.15e-06	6.21e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—EP300—colon cancer	1.15e-06	6.2e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CA—colon cancer	1.12e-06	6.07e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPARG—colon cancer	1.08e-06	5.83e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CA—colon cancer	9.68e-07	5.23e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKT1—colon cancer	9.39e-07	5.08e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKT1—colon cancer	9.18e-07	4.96e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS2—colon cancer	8.49e-07	4.59e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CA—colon cancer	8.48e-07	4.58e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKT1—colon cancer	7.91e-07	4.27e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—EP300—colon cancer	7.06e-07	3.82e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKT1—colon cancer	6.93e-07	3.74e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CA—colon cancer	5.23e-07	2.82e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKT1—colon cancer	4.27e-07	2.31e-05	CbGpPWpGaD
